Search for the latest oncology news by tumour type
RESEARCH SUMMARY Study Title: Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal…
Triple-negative breast cancer, or TNBC, presents numerous treatment challenges. Compared with other forms of breast…
On January 16, 2025, the Food and Drug Administration approved sotorasib with panitumumab for adult…
On January 17, 2025, the Food and Drug Administration approved datopotamab deruxtecan-dlnk, a Trop-2-directed antibody…
A new research paper was published in the journal Ageing titled “DNA-methylation age and accelerated epigenetic…
GSK plc announced today that the European Commission has approved dostarlimab in combination with chemotherapy…
Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the European Commission (EC)…
Bladder cancer has a cure rate of over 90% when detected early, but it has…
By studying biomarkers known to be involved in gastrointestinal cancers, researchers at the Johns Hopkins…
Ovarian cancer, a deadly gynecologic malignancy, has seen a significant shift in its treatment paradigm…